…
Identification of Tetraspanin-7 as a Target of Autoantibodies in Type 1 Diabetes
…
Unraveling the Paradox of Selective Insulin Resistance in the Liver: the Brain-Liver Connection
…
DYRK1A: A Promising Drug Target for Islet Transplant-Based Diabetes Therapies
…
Myeloid Deletion of alpha1AMPK Exacerbates Atherosclerosis in LDL Receptor Knockout (LDLRKO) Mice
…
A NEET Way to Impair Mitochondrial Function in alpha- and beta-Cells
…
Inhibition of DYRK1A Stimulates Human beta-Cell Proliferation
…
Linking MTNR1B Variants to Diabetes: The Role of Circadian Rhythms
…
Targeting AMP Kinase in Myeloid Cells to Reduce Atherosclerosis
…
Erratum. Evidence of Extrapancreatic Glucagon Secretion in Man. Diabetes 2016;65:585-597
…
